Insmed Incorporated Common Stock Earnings Dividend

Insmed Incorporated Common Stock’s revenue jumped 229.62% since last year same period to $305.96Mn in the Q1 2026. On a quarterly growth basis, Insmed Incorporated Common Stock has generated 15.96% jump in its revenue since last 3-months.

Insmed Incorporated Common Stock’s net profit jumped 36.25% since last year same period to $-163.56Mn in the Q1 2026. On a quarterly growth basis, Insmed Incorporated Common Stock has generated 50.21% jump in its net profits since last 3-months.

Insmed Incorporated Common Stock’s net profit margin jumped 80.66% since last year same period to -53.46% in the Q1 2026. On a quarterly growth basis, Insmed Incorporated Common Stock has generated 57.06% jump in its net profit margins since last 3-months.

Insmed Incorporated Common Stock’s earning per share (EPS) estimates for the current quarter stand at -0.75 - a 25% jump from last quarter’s estimates.

Insmed Incorporated Common Stock’s earning per share (EPS) estimates for the current year stand at -0.75.

Insmed Incorporated Common Stock’s earning per share (EPS) jumped 46.48% since last year same period to -0.76 in the Q1 2026. This indicates that the Insmed Incorporated Common Stock has generated 46.48% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Insmed Incorporated Common Stock’s return on assets (ROA) stands at -0.31.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Insmed Incorporated Common Stock’s return on equity (ROE) stands at -2.94.